STRAGEN NORDIC A/S: Financial statements 2016
CVR: 26717825
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
STRAGEN NORDIC A/S (CVR 26717825) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 4,209,533 and a net result of DKK 702,478 compared with DKK -261,217 the year before. That is an increase of 22.5% compared with the year before. Equity in the 2016 report amounted to DKK 3,288,247. The solvency ratio was 30.4%.
- Gross Profit
- DKK 4,209,533
- Profit/Loss
- DKK 702,478
- Equity
- DKK 3,288,247
- Total Assets
- DKK 10,829,840
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 4.2M | 702K | 3.3M | - |
| 2015 | - | 3.4M | -261K | 2.6M | - |
| 2014 | - | 4.3M | 171K | 2.8M | - |
| 2013 | - | 4.6M | -293K | 2.7M | - |
| 2012 | 39.5M | 2.1M | -2.8M | 3M | - |
Official annual report
Find more companies like STRAGEN NORDIC A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
STRAGEN NORDIC A/S has published its annual report for 2015. Gross profit came to DKK 3,437,107, and the net result was DKK -261,217.
About STRAGEN NORDIC A/S
STRAGEN NORDIC A/S is a Danish company of the type Aktieselskab based in Slangerup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anne Franch Nyquist-Hansen and Didier Remi Dargent. The board consists of Didier Remi Dargent (chair), Jean-Yves Paul Etienne Desmottes and Ludovic Alonzi. The company is owned by Strategic Generics France. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,246,350 and a net result of DKK 529,103 compared with DKK 2,665,035 the year before. Equity in the 2025 report amounted to DKK 9,440,623.